Skip to Content

Immuno, Volume 3, Issue 4

2023 December - 2 articles

Cover Story: Liver fibrosis is a complex, dynamic process associated with a broad spectrum of chronic and acute liver diseases. It is defined by the dysregulated intrahepatic production of extracellular matrix proteins, replacing functional liver cells with scar tissue, resulting in cirrhosis and liver failure. Despite the global burden of the disease, no existing therapies can treat or reverse hepatic fibrosis. In this review, we summarise the current understanding of the intricate inflammatory network central to liver fibrogenesis, with a focus on the role of regulatory T cells. We also discuss the advancements in therapeutics, including T cell immunotherapies, which show promise as effective treatments for liver fibrosis. Further work is required to better define the function of immune cells in fibrosis to enable the rationale design of better treatments. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (2)

  • Review
  • Open Access
16 Citations
9,426 Views
34 Pages

Inflammatory Network of Liver Fibrosis and How It Can Be Targeted Therapeutically

  • Kirstin O. Lowe,
  • Constantin E. Tanase,
  • Susan Maghami,
  • Leanne E. Fisher and
  • Amir M. Ghaemmaghami

28 November 2023

Liver fibrosis is a complex, dynamic process associated with a broad spectrum of chronic liver diseases and acute liver failure, characterised by the dysregulated intrahepatic production of extracellular matrix proteins replacing functional liver cel...

(This article belongs to the Section Clinical/translational Immunology)
  • Article
  • Open Access
1 Citations
2,837 Views
17 Pages

High-Avidity Anti-Filovirus IgG Elicited Using Protein Subunit Vaccines Does Not Correlate with Protection

  • Caitlin A. Williams,
  • Teri Ann S. Wong,
  • Michael M. Lieberman,
  • Jake Yalley-Ogunro and ,
  • Mehtap Cabus,
  • Sara Nezami,
  • Fabian Paz,
  • Hanne Andersen,
  • Thomas W. Geisbert and
  • Axel T. Lehrer
  • + 5 authors+ 0 author

24 October 2023

Zaire ebolavirus (EBOV) poses a significant threat to public health due to its high case fatality rate and epidemic potential. This is further complicated by the lack of precise immune correlates of protection and difficulties in conducting in vivo a...

(This article belongs to the Section Infectious Immunology and Vaccines)
XFacebookLinkedIn
Immuno - ISSN 2673-5601